Abstract Background Anti-androgen resistance remains a major clinical challenge in the treatment of prostate cancer (PCa). leading to disease progression and treatment failure. Despite extensive research on resistance mechanisms. a reliable prognostic model for predicting patient outcomes and guiding therapeutic strategies is still lacking. https://www.markbroyard.com/best-save-happy-way-ashy-bines-whey-protein-powder-choc-caramel-500g-online-sale-big-deal/